Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 214.17M | 215.74M | 201.52M | 200.40M | 161.41M |
| Total Receivables | 84.37M | 84.99M | 79.80M | 79.36M | 72.08M |
| Inventory | 32.23M | 32.46M | 27.19M | 27.04M | 28.45M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.10M | 8.16M | 8.95M | 8.90M | 11.51M |
| Total Current Assets | 338.87M | 341.35M | 317.46M | 315.70M | 273.45M |
|
|
|||||
| Total Current Assets | 338.87M | 341.35M | 317.46M | 315.70M | 273.45M |
| Net Property, Plant & Equipment | 20.78M | 20.93M | 22.89M | 22.76M | 22.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 282.20K | 284.20K | 467.90K | 465.30K | 421.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.92M | 8.99M | 14.81M | 14.73M | 16.99M |
| Total Assets | 368.86M | 371.56M | 355.63M | 353.66M | 312.90M |
|
|
|||||
| Total Accounts Payable | 17.30M | 17.42M | 18.99M | 18.88M | 12.48M |
| Total Accrued Expenses | 28.21M | 28.42M | 30.14M | 29.97M | 20.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.55M | 2.57M | 2.60M | 2.59M | 2.59M |
| Total Finance Division Other Current Liabilities | 3.32M | 3.34M | 10.34M | 10.28M | 7.76M |
| Total Other Current Liabilities | 3.32M | 3.34M | 10.34M | 10.28M | 7.76M |
| Total Current Liabilities | 51.38M | 51.75M | 62.07M | 61.72M | 43.25M |
|
|
|||||
| Total Current Liabilities | 51.38M | 51.75M | 62.07M | 61.72M | 43.25M |
| Long-Term Debt | 87.43M | 88.07M | 95.14M | 94.61M | 103.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.29M | 13.39M | 14.77M | 14.69M | 16.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.83M | 15.95M | 22.31M | 22.18M | 20.84M |
| Total Liabilities | 167.93M | 169.16M | 194.28M | 193.21M | 183.19M |
|
|
|||||
| Common Stock & APIC | 1.32B | 1.33B | 1.34B | 1.34B | 1.34B |
| Retained Earnings | -1.06B | -1.07B | -1.11B | -1.11B | -1.14B |
| Treasury Stock & Other | -63.80M | -64.27M | -69.59M | -69.20M | -66.88M |
| Total Common Equity | 200.93M | 202.40M | 161.35M | 160.45M | 129.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 200.93M | 202.40M | 161.35M | 160.45M | 129.71M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 200.93M | 202.40M | 161.35M | 160.45M | 129.71M |
|
|
|||||